Publications by authors named "Leonardo Forero"

Claim this Profile
C
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study.
Jordi Rodon, Mitchell Garrison, Lisa A Hammond, Johann de Bono, Lon Smith, Leonardo Forero

Cancer Chemother Pharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer.
Chris H Takimoto, Lisa A Hammond-Thelin, Jane E Latz, Leonardo Forero, Muralidhar Beeram

Clin Cancer Res· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
Monica M Mita, Eric K Rowinsky, Leonardo Forero, S Gail Eckhart, Elzbieta Izbicka

Cancer Chemother Pharmacol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors.
Alejandro D Ricart, Lisa A Hammond, John G Kuhn, Chris H Takimoto, Andrew Goetz, Leonardo Forero

Clin Cancer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis